Cargando…
Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma
BACKGROUND: The resulting clinical impact of the combined use of G-CSF with chemotherapy as a chemosensitizing strategy for treatment of acute myeloid leukemia (AML) patients is still controversial. In this study, the effect of ex vivo treatment with G-CSF on AML primary blasts was studied. METHODS:...
Autores principales: | Nomdedeu, Meritxell, Lara-Castillo, María Carmen, Etxabe, Amaia, Cornet-Masana, Josep María, Pratcorona, Marta, Díaz-Beyá, Marina, Calvo, Xavier, Rozman, María, Costa, Dolors, Esteve, Jordi, Risueño, Ruth M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687155/ https://www.ncbi.nlm.nih.gov/pubmed/26696777 http://dx.doi.org/10.1186/s12935-015-0272-3 |
Ejemplares similares
-
Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells
por: Cornet-Masana, Josep Maria, et al.
Publicado: (2016) -
Repositioning of bromocriptine for treatment of acute myeloid leukemia
por: Lara-Castillo, María Carmen, et al.
Publicado: (2016) -
Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML
por: Banús-Mulet, Antònia, et al.
Publicado: (2018) -
XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells
por: Moreno-Martínez, Daniel, et al.
Publicado: (2014) -
The lincRNA HOTAIRM1, located in the HOXA genomic region, is expressed in acute myeloid leukemia, impacts prognosis in patients in the intermediate-risk cytogenetic category, and is associated with a distinctive microRNA signature
por: Díaz-Beyá, Marina, et al.
Publicado: (2015)